Neurology Letters
Keywords = Multiple sclerosis
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Yazdan Panah; Yousef Mokary; Arshia Ghalamkari; Ahmad Pourmohammadi; Saba Naghavi; Iman Adibi; Fereshteh Ashtari
Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Abolhasani; Shima Ghannadi
Multiple sclerosis and legal medicine (ORP-34)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammadreza Motamed
Optic neuritis and autoimmune optic neuropathies (ORP-35)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Samira Navardi
Effect of dynamic neuromuscular stabilization on fatigue and spasticity in people with multiple sclerosis: a randomized controlled trial (ORP-37)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Laleh Abadi Marand
Multiple sclerosis, infectious and Gastrointestinal complications (ORP-39)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hora Heidari
Multiple sclerosis, Pregnancy, Breastfeeding (ORP-40)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hora Heidari
Patients monitoring during treatment with Teriflunomide (ORP-41)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nahid Hoseini Nejad Mir
The Role of Advanced MRI Techniques and Artificial Intelligence-based Methods In Diagnosis of Multiple Sclerosis (ORP-42)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vahid Shahmaei
Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehran Ghaffari
Treatment escalation vs early high efficacy treatment in multiple sclerosis (cons and pros) (ORP-45)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Baghbanian
Nutritional recommendations in multiple sclerosis patients: a narrative review (ORP-46)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nasim Rezaeimanesh
Paroxysmal Events in Multiple Sclerosis (MS); Pseudoathetosis as a Presenting Symptom of MS (ORP-48)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ahmad Chitsaz
Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nazanin Razazian
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Adrina Habibzadeh; Sara Dehghani; Samin Shiati
Management of seizure in patients with multiple sclerosis (ORP-51)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Akbar Asadi-Pooya
The role of stereotactic biopsy in atypical brain lesions (ORP-52)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sohrab Shahzadi
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Saba Naghavi; Fereshteh Ashtari; Aryan Kavosh; Ahmad Pourmohammadi; Iman Adibi; Arshia Ghalamkari; Zahra Karimi
System biology review of multiple sclerosis and discovery of drug targets (ORP-54)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Alizadeh Amiri
Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vahid Shaygannejad
A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sanaz Heydari
Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zhila Maghbooli
Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Reza Hajmanouchehri
MS and Environmental Factors (ORP-61)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehdi Moghadasi
Care ethics and empathic Practices in dealing with MS Patients (ORP-62)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hanieh Zaer Rezaei
)